UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$475M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$349M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$346M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$261M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.91B |
| 2 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.28B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.17B |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$1.11B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$968M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.93% |
| 2 | Financials | 6.61% |
| 3 | Consumer Discretionary | 6.23% |
| 4 | Healthcare | 5.77% |
| 5 | Communication Services | 4.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6401
VistaGen Therapeutics
VTGN
$11.9M
| $39K | ﹤0.01% |
670
-6
| -0.9% | -$153 |
|
|
ESSCU
6402
DELISTED
East Stone Acquisition Corporation Unit
ESSCU
| $39K | ﹤0.01% |
3,517
+3,235
| +1,147% | +$33.2K |
|
|
NBEV
6403
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $39K | ﹤0.01% |
15,016
+14,516
| +2,903% | +$39.4K |
|
|
FCCY
6404
DELISTED
1st Constitution Bancorp
FCCY
| $39K | ﹤0.01% |
2,458
+1,866
| +315% | +$27.9K |
|
|
HPR
6405
DELISTED
HighPoint Resources Corporation
HPR
| $39K | ﹤0.01% |
4,281
+4,251
| +14,170% | +$39.5K |
|
|
AVEO
6406
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $39K | ﹤0.01% |
6,705
+5,988
| +835% | +$34.3K |
|
6407
Alico
ALCO
$307M
| $38K | ﹤0.01% |
1,215
+670
| +123% | +$20.6K |
|
6408
Alto Ingredients
ALTO
$323M
| $38K | ﹤0.01% |
7,056
+7,034
| +31,973% | +$48.8K |
|
6409
Asure Software
ASUR
$243M
| $38K | ﹤0.01% |
5,286
+1,116
| +27% | +$8.51K |
|
|
STEX
6410
Streamex Corp
STEX
$83M
| $38K | ﹤0.01% |
981
+388
| +65% | +$17.1K |
|
6411
CalciMedica
CALC
$10.4M
| $38K | ﹤0.01% |
93
+70
| +304% | +$20.7K |
|
|
DHY
6412
Credit Suisse High Yield Credit Fund
DHY
$242M
| $38K | ﹤0.01% |
16,960
+5,534
| +48% | +$12.3K |
|
6413
Graham Corp
GHM
$1.28B
| $38K | ﹤0.01% |
2,462
+1,726
| +235% | +$25.4K |
|
6414
Harvard Bioscience
HBIO
$27.6M
| $38K | ﹤0.01% |
895
+789
| +744% | +$29.4K |
|
6415
Mayville Engineering Co
MEC
$574M
| $38K | ﹤0.01% |
2,786
-441
| -14% | -$4.88K |
|
6416
Northeast Bank
NBN
$1.15B
| $38K | ﹤0.01% |
1,676
+706
| +73% | +$14.9K |
|
6417
PUT
Newell Brands
NWL
$2.62B
| $38K | ﹤0.01% |
+1,800
| New | +$35.1K |
|
6418
Pure Cycle
PCYO
$275M
| $38K | ﹤0.01% |
3,396
+2,633
| +345% | +$26.1K |
|
6419
PhenixFIN
PFX
$88.9M
| $38K | ﹤0.01% |
1,331
-608
| -31% | -$14.2K |
|
6420
Invesco S&P SmallCap Materials ETF
PSCM
$21.7M
| $38K | ﹤0.01% |
671
| – | – |
|
6421
RBB Bancorp
RBB
$458M
| $38K | ﹤0.01% |
+2,492
| New | +$35.4K |
|
|
SNCR
6422
DELISTED
Synchronoss Technologies
SNCR
| $38K | ﹤0.01% |
+906
| New | +$26.2K |
|
6423
PUT
Steris
STE
$23.2B
| $38K | ﹤0.01% |
200
| – | – |
|
6424
Travere Therapeutics
TVTX
$5.68B
| $38K | ﹤0.01% |
+1,422
| New | +$33.2K |
|
6425
Unity Bancorp
UNTY
$609M
| $38K | ﹤0.01% |
2,192
+941
| +75% | +$14.9K |
|
Similar funds
UBS Group's Q4 2020 Portfolio in Review
As of Q4 2020, UBS Group held 9,236 positions worth $296B, up 11% from $265B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q4 2020 filing shows 1,125 new, 3,976 increased, 2,989 reduced and 738 closed positions. Its largest new stake was Vontier: 502,899 shares worth $16.8M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.91B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
- UBS Group's largest Q4 2020 buy was Vontier: 502,899 shares worth $16.8M.
- UBS Group added most to UBS Group in Q4 2020, an estimated $475M increase.
- UBS Group's biggest Q4 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.91B.
- UBS Group fully exited Delphi Technologies PLC Ordinary Shares in Q4 2020, selling an estimated $96.7M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q4 2020.
- UBS Group opened 1,125 new positions and closed 738 in Q4 2020.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.